SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-14-163493
Filing Date
2014-04-28
Accepted
2014-04-28 17:23:33
Documents
10
Effectiveness Date
2014-04-28

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS d717043ddefa14a.htm DEFA14A 32801
2 GRAPHIC g717043notice_pg001a.jpg GRAPHIC 43667
3 GRAPHIC g717043notice_pg001b.jpg GRAPHIC 28037
4 GRAPHIC g717043notice_pg001c.jpg GRAPHIC 4349
5 GRAPHIC g717043notice_pg001d.jpg GRAPHIC 19287
6 GRAPHIC g717043notice_pg001e.jpg GRAPHIC 9768
7 GRAPHIC g717043notice_pg001f.jpg GRAPHIC 2576
8 GRAPHIC g717043notice_pg001g.jpg GRAPHIC 3287
9 GRAPHIC g717043notice_pg001h.jpg GRAPHIC 3749
10 GRAPHIC g717043notice_pg002.jpg GRAPHIC 3348
  Complete submission text file 0001193125-14-163493.txt   197928
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Filer) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35993 | Film No.: 14790533
SIC: 2834 Pharmaceutical Preparations